Stay updated on Alirocumab vs Statin for Neoatherosclerosis Clinical Trial
Sign up to get notified when there's something new on the Alirocumab vs Statin for Neoatherosclerosis Clinical Trial page.

Latest updates to the Alirocumab vs Statin for Neoatherosclerosis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer’s software revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check22 days agoChange DetectedA sitewide NIH notice says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and provides a link to updates and FAQs.SummaryDifference0.8%

- Check29 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov interface as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedThe footer’s site revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry (v3.7.0) was added to the study record history, and the previous revision (v3.6.6) was removed.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry, v3.6.6, is added to the study's record history. This update supersedes the previous revision, v3.6.5, and reflects a maintenance change to the record.SummaryDifference0.1%

Stay in the know with updates to Alirocumab vs Statin for Neoatherosclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab vs Statin for Neoatherosclerosis Clinical Trial page.